Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2019/12/17
-
Journal
-
Indian UGC (journal)
-
Refrences47
-
Citations38
-
Eva Rajha Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
-
Patrick Chaftari Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
-
Mona Kamal Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
-
Julian Maamari Schoool of Medicine, Lebanese American University, Byblos, Lebanon
-
Christopher Chaftari Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, USA
-
Sai-Ching Jim Yeung Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Abstract
Cite
Rajha, Eva, et al. “Gastrointestinal Adverse Events Associated With Immune Checkpoint Inhibitor Therapy”. Gastroenterology Report, vol. 8, no. 1, 2019, pp. 25-30, https://doi.org/10.1093/gastro/goz065.
Rajha, E., Chaftari, P., Kamal, M., Maamari, J., Chaftari, C., & Yeung, S.-C. J. (2019). Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy. Gastroenterology Report, 8(1), 25-30. https://doi.org/10.1093/gastro/goz065
Rajha E, Chaftari P, Kamal M, Maamari J, Chaftari C, Yeung SCJ. Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy. Gastroenterology Report. 2019;8(1):25-30.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the digestive system
Gastroenterology
Medicine
Medicine (General)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases | Journal of Cancer Research and Clinical Oncology |
| 52 | 2019 |
| Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies? | Journal of Hepatology |
| 43 | 2019 |
| Diabetic ketoacidosis induced by a single dose of pembrolizumab | The American Journal of Emergency Medicine |
| 28 | 2019 |
| Immune-related pancreatitis associated with checkpoint blockade in melanoma | Melanoma Research |
| 2019 | |
Can Immune Checkpoint Inhibitors Induce Microscopic Colitis or a Brand New Entity? | Inflammatory Bowel Diseases |
| 52 | 2019 |
Refrences Analysis
The category
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 25
is the most frequently represented among the references in this article. It primarily includes studies from Journal of Clinical Oncology and Journal for ImmunoTherapy of Cancer. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Enterocolitis y otras manifestaciones de toxicidad gastrointestinal asociada a inmunoterapia y terapia blanco: una revisión para el gastroenterólogo | Revista de Gastroenterología de México |
| 2024 | |
| Enterocolitis and other immunotherapy and targeted therapy-related gastrointestinal manifestations: A review for gastroenterologist | Revista de Gastroenterología de México (English Edition) | 2024 | ||
Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis | Frontiers in Immunology |
| 2024 | |
Immune checkpoint inhibitor-associated gastritis: Patterns and management | World Journal of Gastroenterology |
| 2024 | |
| Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors | Journal of Cancer Research and Clinical Oncology |
| 2 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 20
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Excretory/Secretory Products From Trichinella spiralis Adult Worms Attenuated DSS-Induced Colitis in Mice by Driving PD-1-Mediated M2 Macrophage Polarization and was published in 2020. The most recent citation comes from a 2024 study titled Immune checkpoint inhibitor-associated gastritis: Patterns and management. This article reached its peak citation in 2023, with 15 citations. It has been cited in 32 different journals, 31% of which are open access. Among related journals, the Frontiers in Immunology cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.